Published Evidence vs Community Protocols Where each AOD-9604 cycle claim comes from Claim AOD-9604 was studied for 12 weeks Published human support Yes, using oral doses Community support Often used as a community timeline How it should be described Published duration, but not a proven SubQ cycle Claim AOD-9604 was studied for 24 weeks Published human support Yes, using oral tablets Community support Sometimes used to justify longer plans How it should be described Published oral trial
Furthermore, insulin resistance has many contributing factors, including genetics, sleep, physical activity, body composition, medications, nutrition, hormones, and medical conditions
It has been used to treat neurological diseases such as Huntingtons chorea, Tourettes disease, cerebellar ataxia and certain types of seizures
Scientific Reports Kraus et al
PMID: 11225715 Shortened GH peptide (AOD9604) stimulates lipolysis and inhibits lipogenesis both in vitro and in vivo